Description: Session 9B: Negotiated Drugs - How the IRA Program Impacts the PD Ecosystem

Description: Welcome and Keynote

Description: Session 6D: Breaking Barriers - A Multidimensional Approach to Behavioral Healthcare Access

Description: Session 1B: Navigating the Future Pharmacy Pricing Trends for Actuaries

Description: Session 6F: Consumer Value - Can New Health Plan Designs Improve Cost, Quality and Transparency?

Description: Session 5E: The Health Societal Purpose of the Actuarial Profession

Description: Session 7G: The Battle for Small Groups

Description: Explore a brief overview of federal income taxation of health insurers and selected technical tax topics during this panel discussion webcast. You'll dive into the evolution of heath insurers and healthcare-related services and the arising questions regarding their risk-bearing activities, as well as whether or not certain types of healthcare businesses qualify as "insurance companies" for federal income tax purposes. Also, expect to learn about loss reserves for guaranteed renewable contracts and how they can affect insurance company tax status. This webcast will continue to highlight how the IRS challenges loss reserves of health insurers as the panelists review the status of tax cases, IRS guidance and recent IRS activity regarding "margins."

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: After three decades of relatively stable overall inflation trends, the United States has seen significant increases over the last twelve months. What could this mean for inflation in the medical sector? Explore past patterns between the two phenomena, and what drivers stakeholders can monitor to be best aware of what could be coming.